Home
About
Overview
Sharing Data
ORCID
Help
History (23)
Mechanism of factor VIII inactivation by human antibodies. IV. Antibody binding prevents factor VIII proteolysis by thrombin.
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
Protocol for Single-Stage Bilateral Temporomandibular Joint Replacement Using Intraoperative Navigation in Patients With Ankylosis.
Molecular viral oncology of hepatocellular carcinoma.
Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins.
Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins. Biochem J. 2011 Oct 15; 439(2):299-311.
View in:
PubMed
subject areas
Animals
Carrier Proteins
Cell Line
Down-Regulation
Mice
Mice, Inbred BALB C
Spectrometry, Mass, Electrospray Ionization
Sphingolipids
Tandem Mass Spectrometry
authors with profiles
Michael B. Lilly